AnalystsBrandon FolkesBrandon Folkes's Stock Forecasts
AnalystsBrandon Folkes
Analyst Ranking
Bottom 1%
#4547 out of 4563 analysts
Average Return
-25.69%
Win Rate
19%6 out of 31
Risk vs Reward
Poor
Good
Brandon Folkes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Elutia IncELUT | +102.10% | $1.43 | $2.89 | 2023-08-14 - 2024-04-24 | Strong Buy |
Ani Pharmaceuticals IncANIP | +29.11% | $57.06 | $73.67 | 2018-08-07 - 2019-08-08 | Strong Buy |
Elutia IncELUT | +24.57% | $2.32 | $2.89 | 2023-05-11 - 2024-04-24 | Strong Buy |
Alkermes PLCALKS | +16.04% | $24.56 | $28.50 | 2022-01-26 - 2023-01-26 | Strong Buy |
Amryt Pharma PLCAMYT | +4.18% | $11.00 | $11.46 | 2020-07-08 - 2021-07-08 | Strong Buy |
Brandon Folkes Analyst Color
Get additional color on Brandon Folkes's coverage of popular stocks
Brandon Folkes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sanara Medtech IncSMTI | 4 | Strong Buy | $59.00 | +81.54% | Reiterates | 7 months ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $180.00 | +66.17% | Reiterates | 8 months ago |
Elutia IncELUT | 3 | Strong Buy | $8.00 | +176.82% | Reiterates | 8 months ago |
Amryt Pharma PLCAMYT | 2 | Hold | $14.75 | N/A | Downgrades | a year ago |
Veru IncVERU | 2 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Sorrento Therapeutics IncSRNEQ | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Obseva SaOBSVF | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Journey Medical CorpDERM | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Alkermes PLCALKS | 1 | Strong Buy | $32.00 | N/A | Upgrades | 2 years ago |
Imv IncIMVIQ | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Redhill Biopharma LtdRDHL | 1 | Strong Buy | $880.00 | N/A | Initiates Coverage On | 3 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Collegium Pharmaceutical IncCOLL | 3 | Hold | $22.00 | N/A | Downgrades | 3 years ago |
Polypid LtdPYPD | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 3 years ago |
Trevena IncTRVN | 1 | Strong Buy | $125.00 | N/A | Initiates Coverage On | 4 years ago |
Emergent Biosolutions IncEBS | 3 | Strong Buy | $110.00 | N/A | Maintains | 4 years ago |
Ani Pharmaceuticals IncANIP | 2 | Hold | $40.00 | N/A | Downgrades | 4 years ago |
Optinose IncOPTN | 1 | Strong Buy | $21.00 | N/A | Reiterates | 4 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Hold | $46.00 | N/A | Maintains | 4 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $30.00 | N/A | Reiterates | 4 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Strong Buy | $42.00 | N/A | Maintains | 6 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Strong Buy | $50.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.